Literature DB >> 27115403

UK Renal Registry 18th Annual Report (December 2015) Chapter 5: Survival and Causes of Death in UK Adult Patients on Renal Replacement Therapy in 2014: National and Centre-specific Analyses.

Retha Steenkamp1, Anirudh Rao, Simon Fraser.   

Abstract

Survival of incident patients on RRT continued to improve over the last 14 years for both short and long term survival up to 10 years post RRT start. One year after 90 day age adjusted survival for incident RRT patients in the 2013 cohort increased to 91.4% from the previous year (91.0%); survival increased in incident patients aged ,65 years and in older patients (565 years). There was a difference in one year after 90 day incident survival by age group and diabetic status: diabetic patients aged ,65 years have slightly worse survival than non-diabetic patients, but survival for older diabetic patients (565 years) was significantly better than for non-diabetic patients. One year age adjusted survival for prevalent dialysis patients was 88.6% in the 2013 cohort, a slight decrease from the 2012 cohort (89.3%). Age adjusted one year survival for prevalent dialysis patients with diabetic primary renal disease has been declining slightly since 2012. Centre and UK country variability was evident in incident and prevalent patient survival after adjusting to age 60 and this finding would benefit from further investigation. The relative one year risk of death on RRT decreased with age from about 19 times that of the general population at age 35–39 years to 2.6 times at age 85 and over. In the prevalent RRT population, cardiovascular disease was the most common cause of death, accounting for 23% of deaths. Infection accounted for 20% of deaths and treatment withdrawal for 16% of deaths.

Entities:  

Mesh:

Year:  2016        PMID: 27115403     DOI: 10.1159/000444819

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  13 in total

1.  Gradual initiation of dialysis as a means to reduce cost while providing quality health care.

Authors:  Mohamed E Elrggal; Rowan Zyada
Journal:  Nat Rev Nephrol       Date:  2017-09-25       Impact factor: 28.314

Review 2.  How long do patients with chronic disease expect to live? A systematic review of the literature.

Authors:  Barnaby Hole; Joseph Salem
Journal:  BMJ Open       Date:  2016-12-29       Impact factor: 2.692

3.  Prediction models for the mortality risk in chronic dialysis patients: a systematic review and independent external validation study.

Authors:  Chava L Ramspek; Pauline Wm Voskamp; Frans J van Ittersum; Raymond T Krediet; Friedo W Dekker; Merel van Diepen
Journal:  Clin Epidemiol       Date:  2017-09-05       Impact factor: 4.790

4.  The clinical epidemiology of young adults starting renal replacement therapy in the UK: presentation, management and survival using 15 years of UK Renal Registry data.

Authors:  Alexander J Hamilton; Anna Casula; Yoav Ben-Shlomo; Fergus J Caskey; Carol D Inward
Journal:  Nephrol Dial Transplant       Date:  2018-02-01       Impact factor: 5.992

5.  Humoral immunity to memory antigens and pathogens is maintained in patients with chronic kidney disease.

Authors:  Nadezhda A Wall; C Coral Dominguez-Medina; Sian E Faustini; Charlotte N Cook; Andrew McClean; Mark D Jesky; Marisol Perez-Toledo; Matthew D Morgan; Alexandra G Richter; Charles J Ferro; Paul Cockwell; Paul A Moss; Ian R Henderson; Lorraine Harper; Adam F Cunningham
Journal:  PLoS One       Date:  2018-04-16       Impact factor: 3.240

6.  Inequality in Care and Differences in Outcome Following Stroke in People With ESRD.

Authors:  Mark D Findlay; Jesse Dawson; Rachael MacIsaac; Alan G Jardine; Mary Joan MacLeod; Wendy Metcalfe; Jamie P Traynor; Patrick B Mark
Journal:  Kidney Int Rep       Date:  2018-04-27

7.  A randomized controlled trial of different serum phosphate ranges in subjects on hemodialysis.

Authors:  Ramya Bhargava; Philip A Kalra; Mark Hann; Paul Brenchley; Helen Hurst; Alastair J Hutchison
Journal:  BMC Nephrol       Date:  2019-02-04       Impact factor: 2.388

8.  Benefits and harms of high-dose haemodiafiltration versus high-flux haemodialysis: the comparison of high-dose haemodiafiltration with high-flux haemodialysis (CONVINCE) trial protocol.

Authors:  Peter J Blankestijn; Kathrin I Fischer; Claudia Barth; Krister Cromm; Bernard Canaud; Andrew Davenport; Diederick E Grobbee; Jörgen Hegbrant; Kit C Roes; Matthias Rose; Giovanni Fm Strippoli; Robin Wm Vernooij; Mark Woodward; G Ardine de Wit; Michiel L Bots
Journal:  BMJ Open       Date:  2020-02-05       Impact factor: 2.692

9.  Intravenous drug users who require dialysis: causes of renal failure and outcomes.

Authors:  Jemima K Scott; Dominic M Taylor; Chris R K Dudley
Journal:  Clin Kidney J       Date:  2017-08-31

10.  Lipid levels are inversely associated with infectious and all-cause mortality: international MONDO study results.

Authors:  George A Kaysen; Xiaoling Ye; Jochen G Raimann; Yuedong Wang; Alice Topping; Len A Usvyat; Stefano Stuard; Bernard Canaud; Frank M van der Sande; Jeroen P Kooman; Peter Kotanko
Journal:  J Lipid Res       Date:  2018-06-12       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.